These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 32891506)

  • 1. [Single, immediate postoperative intra-vesical instillation (SI) compared to a single preoperative intra-vesical instillation of mitomycin C in non-muscle invasive bladder cancer (NMIBC). Phase II randomized trial].
    Breton J; Bernardeau S; Vallée M; Pillot P; Lebacle C; Delpech PO; Charles T; Biscans C; Vallat A; Pfister C; Irani J
    Prog Urol; 2021 Feb; 31(2):63-70. PubMed ID: 32891506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
    Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
    Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of an Immediate Intravesical Instillation of Mitomycin C in Patients with Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Randomised Study in 2243 patients.
    Bosschieter J; Nieuwenhuijzen JA; van Ginkel T; Vis AN; Witte B; Newling D; Beckers GMA; van Moorselaar RJA
    Eur Urol; 2018 Feb; 73(2):226-232. PubMed ID: 28705539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial Carcinoma of the Bladder: Which Patients Benefit from the Instillation?
    Sylvester RJ; Oosterlinck W; Holmang S; Sydes MR; Birtle A; Gudjonsson S; De Nunzio C; Okamura K; Kaasinen E; Solsona E; Ali-El-Dein B; Tatar CA; Inman BA; N'Dow J; Oddens JR; Babjuk M
    Eur Urol; 2016 Feb; 69(2):231-44. PubMed ID: 26091833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment].
    Neuzillet Y; Colin P; Comperat E; Dubosq F; Houede N; Larre S; Masson-Lecomte A; Pignot G; Puech P; Roumiguie M; Xylinas E; Mejean A; Roupret M
    Prog Urol; 2016 Mar; 26(3):181-90. PubMed ID: 26777686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HELENA study: Hexvix
    Gierth M; Breyer J; Zeman F; Fritsche HM; Cordes J; Karl A; Zaak D; Stenzl A; von Schmeling IK; Sommerhuber A; Zierer T; Burger M; Mayr R
    World J Urol; 2021 Oct; 39(10):3799-3805. PubMed ID: 34002265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison Between Intravesical Chemotherapy Epirubicin and Mitomycin-C after TURB vs TURB Alone With Recurrence Rate of Non-Muscle Invasive Bladder Cancer: Meta-Analysis.
    Daryanto B; Purnomo AF; Seputra KP; Budaya TN
    Med Arch; 2022 Jun; 76(3):198-201. PubMed ID: 36200115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of the optimization of the conditions of mitomycin C intravesical instillation completion in the setting of non-muscle invasive bladder cancer treatment].
    Lailler G; Neuzillet Y; Rouanne M; Lebret T
    Prog Urol; 2016 Feb; 26(2):79-82. PubMed ID: 26653577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablative Intravesical Chemotherapy for Small Recurrent Non-Muscle-Invasive Bladder Cancer: A Prospective Study.
    Decaestecker K; Lumen N; Ringoir A; Oosterlinck W
    Urol Int; 2016; 96(1):14-9. PubMed ID: 25791565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indication for a Single Postoperative Instillation of Chemotherapy in Non-muscle-invasive Bladder Cancer: What Factors Should Be Considered?
    Babjuk M; Burger M; Compérat EM; Gontero P; Mostafid HA; Palou J; van Rhijn BWG; Rouprêt M; Shariat SF; Sylvester R; Zigeuner R; Capoun O; Cohen D; Dominguez-Escrig JL; Hernández V; Peyronnet B; Seisen T; Soukup V;
    Eur Urol Focus; 2018 Jul; 4(4):525-528. PubMed ID: 30061076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized controlled trial of postoperative early intravesical chemotherapy with pirarubicin (THP) for solitary non-muscle invasive bladder cancer comparing single and two-time instillation.
    Tanimoto R; Saika T; Ebara S; Kobayashi Y; Nasu R; Yamada D; Takamoto H; Miyaji Y; Nasu Y; Tsushima T; Kumon H
    World J Urol; 2018 Jun; 36(6):889-895. PubMed ID: 29387931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C.
    Xylinas E; Kent M; Dabi Y; Rieken M; Kluth LA; Al Hussein Al Awamlh B; Ouzaid I; Pycha A; Comploj E; Svatek RS; Lotan Y; Karakiewicz PI; Holmang S; Shariat SF
    Urol Oncol; 2018 Mar; 36(3):89.e1-89.e5. PubMed ID: 29221642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of continuous saline bladder irrigation after transurethral resection in patients with high-grade non-muscle-invasive bladder cancer.
    Onishi T; Sekito S; Shibahara T; Uchida K; Sasaki T
    Scand J Urol; 2018; 52(5-6):385-388. PubMed ID: 30628540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immediate, single intravesical instillation of mitomycin C is of benefit in patients with non-muscle-invasive bladder cancer irrespective of prognostic risk groups.
    Bosschieter J; Nieuwenhuijzen JA; Vis AN; van Ginkel T; Lissenberg-Witte BI; Beckers GMA; van Moorselaar RJA
    Urol Oncol; 2018 Sep; 36(9):400.e7-400.e14. PubMed ID: 30064935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single early instillation of mitomycin C and urinary alkalinization in low-risk non-muscle-invasive bladder cancer: a preliminary study.
    Ersoy H; Yaytokgil M; Karakoyunlu AN; Topaloglu H; Sagnak L; Ozok HU
    Drug Des Devel Ther; 2013; 7():1-6. PubMed ID: 23300343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravesical adjuvant regimen of epitubicin for intermediate risk NMIBC: Feasability study from CC-AFU vessie].
    Rollin P; Xylinas E; Lanz C; Audenet F; Brunelle S; Compérat E; Houédé N; Larré S; Masson-Lecomte A; Pignot G; Roumiguié M; Méjean A; Rouprêt M; Neuzillet Y;
    Prog Urol; 2022 Apr; 32(5):326-331. PubMed ID: 35151544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
    Divrik RT; Yildirim U; Zorlu F; Ozen H
    J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The benefit of a neoadjuvant instillation of chemotherapy in non-muscle invasive bladder cancer: Interim analysis of the PRECAVE randomized clinical trial.
    Carrión DM; Gómez Rivas J; Aguilera Bazán A; Ballesteros Ruiz C; Álvarez-Maestro M; Ríos González E; Martínez-Piñeiro L
    Arch Esp Urol; 2021 Nov; 74(9):883-893. PubMed ID: 34726625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Non-muscle invasive bladder cancer: safety of postoperative EMDA-assisted instillation of mitomycin].
    Rehme C; Niedworok C; Rübben H; Vom Dorp F
    Urologe A; 2015 Feb; 54(2):235-8. PubMed ID: 25316185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant short-term intensive intravesical mitomycin C regimen compared with weekly schedule for low-grade recurrent non-muscle-invasive bladder cancer: preliminary results of a randomised phase 2 study.
    Colombo R; Rocchini L; Suardi N; Benigni F; Colciago G; Bettiga A; Pellucchi F; Maccagnano C; Briganti A; Salonia A; Rigatti P; Montorsi F
    Eur Urol; 2012 Nov; 62(5):797-802. PubMed ID: 22633362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.